Time to get LONG IMAX in Front of Earnings

Post by:

IMAX Corporation (IMAX) is an entertainment company who specializes in theater systems for customers who operate commercial theaters and theaters in museums and science centers. The company’s stock is currently trading around $26.55 in a 52 week range of $23.50-$31.23. The stock has underperformed the market over the past 12 months having only added 5.87% to share prices over that time. Despite this relatively weak performance options action in IMAX in recent weeks has been decidedly bullish. Early in today’s trading session a trader bought 1,215 IMAX Feb 27 calls for $0.90 and sold 1,215 IMAX Mar 23 puts for $0.20. Volume on the Feb 27 call line has now reached 3,200 contracts and will add to open interest of 1,711 on that line. This also adds to the persistent call buying we have seen over the past week.  Although the chart of IMAX is relatively weak we believe that all of this bullish order flow is a signal to get long IMAX.  We will remain long through earnings on the 20th.

Trade: Buying the IMAX Feb 27 Calls for $0.90
Risk: $90 per 1 lot
Reward: Unlimited
Breakeven: $27.90

Andrew Keene
http://keeneonthemarket.com

Submit a Comment

Your email address will not be published. Required fields are marked *

TradeThirsty

Your ultimate source of knowledge about the markets.

Recent Posts

VIP NOTIFICATION SERVICE

TIRED OF BEING THE LAST TO KNOW ABOUT THE LATEST WINNING TRADE?

Join our VIP Notification Service and Be Among The First To Know About All The Latest Trade Ideas, Trading Tips, Highly Profit Potential Trades, and Market Predictions From Our Team of Expert Traders!
Join Text Messaging List
By providing your mobile phone number and clicking on the above button, you agree to receive automated promotional messages from us. By opting into our SMS Program, you agree to our Terms and Conditions and Privacy Policy  
You have to agree on terms in order to proceed to the subscription.

• FREE VIP NOTIFICATIONS •

Get Our Free Daily Trading Videos

Delivered To your Inbox

By submitting your information you agree to our Terms of Service and our Privacy Policy